Kennedy unveils SPECTRA, an ARPA-H program to make autism diagnosis faster
Why it matters
Families wait months, sometimes years, for an autism evaluation. Kennedy used his Children’s Health Defense keynote to announce a federal research program aimed squarely at that bottleneck.

On September 17, 2026, in his keynote at the Children’s Health Defense conference, Secretary Kennedy announced SPECTRA (Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency), to be run by the Advanced Research Projects Agency for Health (ARPA-H) under program manager Russell Shilling.
Kennedy said today’s diagnostic model is outdated, slow and too dependent on a small number of specialists. The program invites organizations to submit tools and technologies that speed up assessment and improve quality of life for autistic people. No funding amount was announced.
SPECTRA is separate from the NIH’s $50 million Autism Data Science Initiative, which funded 13 projects earlier this year.
Source
AJF reporting.
Related coverage

CDC study in Pediatrics: parent-reported autism up 42% in five years, and 120% among preschoolers
This is the federal government’s own survey, published in the flagship pediatrics journal, and it shows autism rising faster than at any point in the CDC’s recent data. Children’s Health Defense asks the question the paper leaves open: what is driving it?

Kennedy launches a federal vaccine-injury push: an NIH clinic, paid VAERS reporting and a rebuilt reporting system
For decades families who reported a reaction after a vaccine were told it was a coincidence. HHS is now building a clinic to study those cases and paying doctors to report them. It is the most concrete step yet toward the vaccine-safety research Kennedy promised.

Appeals court in Boston hears Kennedy’s bid to revive the slimmed-down childhood vaccine schedule
This lawsuit decides whether the January 2026 schedule overhaul and Kennedy’s new ACIP can take effect at all. Until the First Circuit rules, the old schedule stays in force and the reconstituted vaccine committee cannot vote.
